Clinical Trials Directory

Trials / Completed

CompletedNCT06622343

Predictive Modeling of Necrotizing Skin Infections in Snakebite Patients

Risk Factor Analysis and Predictive Modeling for Necrotizing Skin Infections in Venomous Snakebite Patients: A Multicenter Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
99 (actual)
Sponsor
Guangzhou Institute of Respiratory Disease · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This multicenter retrospective study aims to identify the risk factors associated with necrotizing skin infections following venomous snakebites and to develop a predictive model. Clinical data from 99 patients treated between January 2020 and April 2024 at three hospitals in Guangdong Province, China, were analyzed.

Detailed description

Venomous snakebites are a significant public health issue, particularly in tropical and subtropical regions like southern China. Necrotizing skin infections are a severe but relatively rare complication of venomous snakebites, often resulting from delayed treatment and bacterial invasion. This study retrospectively analyzed clinical data from 99 patients with venomous snakebites treated at three hospitals in Guangdong Province between January 2020 and April 2024. The primary objective was to identify the major risk factors associated with the development of necrotizing skin infections and to build a predictive model to assist in clinical decision-making. The study included male and female patients aged 14 years and older. Patients with incomplete medical records, long-term use of immunosuppressants, or underlying immunodeficiency diseases were excluded. Multivariate logistic regression identified the Snakebite Severity Score (SSS), blood glucose levels, and D-dimer levels as significant independent predictors of necrotizing infections.

Conditions

Interventions

TypeNameDescription
DRUGAntivenom SerumIntravenous administration of 6000 IU of antivenom serum was given to patients envenomed by pit vipers. This treatment was based on Chinese guidelines for the management of snakebites. Additionally, patients received supportive treatments, including antibiotics to prevent infection, antihistamines for allergic reactions, and magnesium sulfate for localized swelling and pain relief.
PROCEDUREWound DebridementPatients who did not develop necrotizing skin infections received wound management, including multiple punctures using a three-edged needle for toxin drainage, along with standard wound care and debridement as necessary to prevent infection and promote healing.

Timeline

Start date
2020-01-01
Primary completion
2024-04-01
Completion
2024-04-30
First posted
2024-10-02
Last updated
2024-10-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06622343. Inclusion in this directory is not an endorsement.